Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety and tolerability of the treatment with
lithium in Spinocerebellar Ataxia 2. Moreover, clinical symptoms, neuronal loss, quality of
life and depressive symptoms, will be considered to further investigate the effect of lithium
therapy.